Punjab National Bank

Similar documents
Punjab National Bank

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

2,09,057 1,85,859 2,17, (4.1) NIM

Gillette India. Institutional Equities. 1QFY18 Result Update

Indian Oil Corporation

Institutional Equities

Dalmia Bharat Enterprises

Colgate-Palmolive (India)

Jamna Auto Industries

EBITDA 5,076 3, , EBITDA

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

9,500 7,914 8, NIM

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

18,948 15,784 18, NIM

Punjab National Bank

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Punjab National Bank

Punjab National Bank

3,746 2,551 3, NIM

93,707 77,814 90, NIM

9,807 8,007 9, NIM

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Bharat Financial Inclusion

9,251 7,812 8, NIM

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Indian Oil Corporation

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Operating expenses tracked lower than core total income growth as ABL displayed continued

Institutional Equities

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Institutional Equities

Federal Bank. Institutional Equities. Management Meet Update

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

EBITDA 6,223 6,511 (4.4) 5, EBITDA

State Bank of India. Institutional Equities. 1QFY18 Result Update

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Institutional Equities

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Institutional Equities

Institutional Equities

Institutional Equities

Institutional Equities

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

The Ramco Cements. Institutional Equities. Event Update BUY

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Dalmia Bharat Enterprises

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Dabur India. Institutional Equities. 1QFY19 Result Update

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Institutional Equities

Institutional Equities

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Dalmia Bharat Enterprises

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Initiating Coverage. Uflex Ltd.

Institutional Equities

Institutional Equities

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Valuation and Outlook. Growth (%) PAT (Rs cr)

EBITDA 5,019 4,211 5, EBITDA

Institutional Equities

Institutional Equities

Institutional Equities

Financial summary. Year

E&P To Stay Strong; Consumer Segment To Revive

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY

Transcription:

Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate rating since (1) growth remains an issue for the bank even though (2) asset quality issues are largely behind the bank. Growth remains an issue with (a) Management having guided for domestic credit growth of ~10% for FY19, which is moderate (b) International book degrowth will continue (c) PNB does not sit on an adequate capital buffer with CAR standing at just 10.3% even after recent capital infusion of Rs28.16bn from the union government (d) PNB remains a candidate for RBI s Prompt Corrective Action regime given it still stands in breach of the relevant NPA threshold. Asset quality problems are largely behind the bank with (a) SMA exposure (which PNB considers its watchlist) standing at Rs80bn- Rs100bn (b) Exposure to various erstwhile restructuring dispensations (including 5/25) standing at Rs40bn (c) Slippage in 1QFY19 had stood at Rs73.6bn compared with a past 10-quarter average of Rs203bn with run rate set to decline further. We assign an Accumulate rating on PNB with a Target Price of Rs82, implying a valuation of 1.0x 1HFY21E P/ABV for the standalone bank. Growth remains an issue since domestic credit growth guidance remains moderate, international book will continue to restructure, capital levels are a constraint and PNB remains a candidate for PCA framework: Domestic credit growth guidance of ~10% is moderate and significantly lower than similar sized PSU peer, Bank of Baroda. There is no change to international book s growth outlook as such as restructuring plans continue with a view to make the business more profitable. Thirdly, despite (a) QIP of Rs 50bn in December 2017 (b) Capital infusion of Rs54.73bn in March 2018 and (c) again, of Rs28.16bn, by GOI, in July 2018, Capital Adequacy Ratio stands at 10.3% due to (a) high NPA provisions (b) fraud at Brady House branch. This is still lower than the minimum requirement of 10.875% for Total Capital if Capital Conservation Buffer (CCB) is included and whose breach precludes discretionary capital distribution to shareholders. Lastly, PNB remains a candidate for RBI s PCA framework given it still stands in breach of the relevant NPA threshold with an NNPA ratio of 10.58% as of 1QFY19 (see research note on considerations surrounding PCA for PNB). Asset quality problems are largely behind the bank with limited residual SMA and restructured book: SMA accounts are 1.8%-2.2% of loan book and restructured book (including 5/25) is 0.9% of loan book. NPA addition in 1QFY19 was 64% lower than the past 10-quarter average. NPA accretion run rate is set to move even lower since the 1QFY19 number included (a) A debit of Rs 21.13bn in existing NPA accounts primarily due to devolvement of non-fund exposure, of which residual exposure to NPA accounts is minimal (b) Rs 13bn of abnormally high Agri slippages, mainly due to seasonality (c) Rs11bn of SME slippages, which are also expected to move lower, as per management. Also, importantly, NPA reduction exceeded expectations at Rs84.45bn in 1QFY19. Consequently, the target of NPA reduction of Rs220bn for FY19 may be surpassed. Both funded and non-fund exposures to the specified Brady House account had earlier been declared fraud and provisions of Rs90.4bn (~63% of exposure) have been made as of 1QFY19, with the remaining to be made over the next two quarters. Certain operational metrics look good optically but have to be viewed in their underlying context: Cost of Deposits had declined 11bps QoQ in 1QFY19 to 4.99% but have to be viewed in conjunction with tepid domestic deposits growth of 4.9%. Yield on Advances moved up to 7.99%, up 147bps QoQ and 8bps YoY but were aided by Rs8bn interest income due to recovery on Bhushan steel account. PNB has adopted a strategy of focusing almost exclusively on higher rated corporates to shore up capital and management has decided to charge higher processing fees (lower discounts) on accounts of higher risk sectors but this may not fully offset the former s yield-dilutive impact. Operating expenses de-grew -17% YoY in 1QFY19 due to general cost control but also due to rationalization of both international and domestic businesses. Valuation and outlook: We assign a multiple of 1.0x 1HFY21E P/ABV for the standalone bank and add Rs30 for the value of subsidiaries, arriving at our Target Price of Rs82, at which PNB stock has an upside of 4%. Consequently, we assign an Accumulate Rating on PNB. ACCUMULATE Sector: Banking CMP: Rs79 Target Price: Rs82 Upside: 4% Shivaji Thapliyal Research Analyst shivaji.thapliyal@nirmalbang.com +91-22-6273 8068 Key Data Current Shares O/S (mn) 2,760.6 Mkt Cap (Rsbn/US$bn) 218.9/3.0 52 Wk H / L (Rs) 232/72 Daily Vol. (3M NSE Avg.) 34,267,690 Price Performance (%) 1 M 6 M 1 Yr Punjab National Bank (5.0) (17.9) (44.9) Nifty Index (1.7) 11.7 11.1 Source: Bloomberg

Sep-08 Jan-09 Jun-09 Oct-09 Mar-10 Jul-10 Dec-10 Apr-11 Sep-11 Jan-12 May-12 Oct-12 Feb-13 Jul-13 Nov-13 Apr-14 Aug-14 Dec-14 May-15 Sep-15 Feb-16 Jun-16 Nov-16 Mar-17 Aug-17 Dec-17 Apr-18 Sep-18 Exhibit 1: One-year forward P/BV (x) 2.00 1.80 1.60 1.40 1.20 1.00 0.80 0.60 0.40 0.20 - Source: Company, Nirmal Bang Research P/BVPS Mean +1 SD -1 SD 2 Punjab National Bank

Financials Exhibit 2: Income statement Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Interest income 4,72,760 4,79,958 4,98,317 5,37,918 5,92,326 Interest expenses 3,22,828 3,30,734 3,42,893 3,60,977 3,95,648 Net interest income 1,49,931 1,49,224 1,55,424 1,76,941 1,96,678 Fee income 62,917 56,217 62,848 73,095 86,582 Other income 26,597 32,592 16,269 23,280 25,215 Net revenues 2,39,445 2,38,033 2,34,541 2,73,317 3,08,475 Operating expenses 93,794 1,35,091 1,40,488 1,56,856 1,76,482 -Employee expenses 54,207 91,688 95,597 1,08,126 1,22,368 -Other expenses 39,587 43,403 44,892 48,730 54,114 Operating profit 1,45,651 1,02,942 94,052 1,16,461 1,31,993 Provisions 1,25,536 2,98,693 1,16,161 73,163 68,659 -Loan loss provision 1,31,453 2,29,458 1,08,420 67,062 64,426 -Investment depreciation 4,867 20,272 7,741 6,101 4,233 -Other provisions (10,784) 48,964 - - - PBT 20,115 (1,95,751) (22,109) 43,298 63,335 Tax 6,867 (72,923) (6,633) 12,989 19,000 PAT 13,248 (1,22,828) (15,476) 30,308 44,334 Source: Company, Nirmal Bang Research Exhibit 4: Balance sheet Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Equity capital 4,256 5,521 6,147 6,147 6,147 Reserves & surplus 4,16,719 4,05,222 4,17,280 4,40,183 4,77,111 Shareholders funds 4,20,975 4,10,743 4,23,427 4,46,330 4,83,258 Deposits 62,17,040 64,22,262 67,86,599 73,43,514 80,78,643 -Current deposits 4,58,533 4,03,742 4,41,129 5,06,702 5,65,505 -Saving deposits 21,41,625 22,28,731 23,75,310 26,14,291 29,08,311 -Term deposit 36,16,882 37,89,789 39,70,160 42,22,521 46,04,826 Borrowings 4,07,633 6,08,507 5,27,038 5,45,217 7,69,470 Other liabilities 1,57,657 2,16,789 2,72,709 2,97,013 3,15,020 Total liabilities 72,03,305 76,58,301 80,09,774 86,32,074 96,46,391 Cash/equivalent 8,83,316 9,54,620 9,04,987 9,18,910 10,29,180 Advances 41,94,931 43,37,347 46,40,962 51,05,058 57,17,665 Investments 18,67,254 20,03,060 20,64,223 21,68,544 24,16,029 Fixed assets 62,732 63,493 69,843 76,827 84,510 Other assets 1,95,071 2,99,781 3,29,759 3,62,735 3,99,008 Total assets 72,03,305 76,58,301 80,09,774 86,32,074 96,46,391 Source: Company, Nirmal Bang Research Exhibit 3: Key ratios Y/E March FY17 FY18 FY19E FY20E FY21E Growth (%) NII growth (2.1) (0.5) 4.2 13.8 11.2 Pre-provision profit growth 19.2 (29.3) (8.6) 23.8 13.3 PAT growth (133.3) (1,027.2) NA NA 46.3 Business (%) Deposit growth 12.4 3.3 5.7 8.2 10.0 Advance growth 1.7 3.4 7.0 10.0 12.0 Business growth 7.9 3.3 6.2 8.9 10.8 CD 67.5 67.5 68.4 69.5 70.8 CASA 41.8 41.0 41.5 42.5 43.0 Operating efficiency (%) Cost-to-income 39.2 56.8 59.9 57.4 57.2 Cost-to-assets 1.4 1.8 1.8 1.9 1.9 Productivity (Rsmn) Business per branch 1,500.9 1,540.8 1,613.4 1,709.3 1,841.2 Business per employee 140.9 143.7 153.7 162.8 175.4 Profit per branch 1.9 (17.6) (2.2) 4.2 5.9 Profit per employee 0.2 (1.6) (0.2) 0.4 0.6 Spread (%) Yield on advances 7.9 7.5 7.4 7.5 7.5 Yield on investments 7.3 7.2 7.2 7.2 7.2 Cost of deposits 5.1 4.8 4.7 4.7 4.7 Yield on assets 7.3 7.0 6.9 7.1 7.1 Cost of funds 4.9 4.7 4.6 4.6 4.6 NIMs 2.3 2.2 2.2 2.3 2.4 Capital adequacy (%) Tier I 8.9 7.1 7.8 7.5 7.3 Tier II 2.8 2.1 2.3 2.1 2.7 Total CAR 11.7 9.2 10.1 9.7 10.0 Asset quality (%) Gross NPAs 12.5 18.4 14.5 12.6 11.0 Net NPAs 7.8 11.2 7.8 6.3 5.0 Specific provision coverage 62.8 60.0 66.7 70.2 73.2 Slippage 5.4 10.4 4.0 3.5 2.5 Credit-cost 3.1 5.7 2.0 1.3 1.1 Return (%) RoE 3.3 (29.5) (3.7) 7.0 9.5 RoA 0.2 (1.7) (0.2) 0.4 0.5 RoRWA 0.3 (2.7) (0.3) 0.6 0.8 Per share EPS 6.5 (55.4) (5.0) 9.9 14.4 BV 197.8 148.8 137.8 145.2 157.2 ABV 44.2 (27.6) 19.7 40.4 64.1 Valuation (x) P/E 12.3 (1.4) (15.8) 8.0 5.5 P/BV 0.4 0.5 0.6 0.5 0.5 P/ABV 1.8 (2.9) 4.0 2.0 1.2 Source: Company, Nirmal Bang Research 3 Punjab National Bank

Apr-14 Jun-14 Aug-14 Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Oct-17 Dec-17 Mar-18 May-18 Jul-18 Sep-18 Rating track Date Rating Market price (Rs) Target price (Rs) 28 July 2014 Accumulate 924 975 8 October 2014 Accumulate 878 975 22 October 2014 Accumulate 928 1,030 8 January 2015* Accumulate 205 206 4 February 2015 Accumulate 177 200 11 May 2015 Accumulate 146 160 29 July 2015 Accumulate 143 160 10 February 2016 Sell 88 75 24 May 2016 Sell 72 55 1 August 2016 Sell 124 75 9 November 2016 Sell 141 92 9 February 2017 Sell 152 92 14 February 2017 Sell 142 100 22 May 2017 Sell 160 115 3 Aug 2017 Sell 158 110 8 November 2017 Under Review 191-7 February 2018 Under Review 161-16 May 2018 Under Review 84-9 August 2018 Under Review 80-19 September 2018 Accumulate 79 82 * Post stock split Rating track graph 250 230 210 190 170 150 130 110 90 70 50 Not Covered Covered 4 Punjab National Bank

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Shivaji Thapliyal, the research analyst is the author of this report, hereby certifies that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 5 Punjab National Bank

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 6273 8017 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 8230, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 8100/8101, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 8102/8103, +91 22 6636 8830 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-400013. Board No. : 91 22 6273 8000/1; Fax. : 022 6273 8010 6 Punjab National Bank